Delivery Order SPE2DB22D3004-SPE2DB25FND17

Award Date 10/7/24
Potential Completion Date 10/8/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,112.72, is for the supply of Emgality 120 mg/ml medications. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,005.44 firm fixed-price contract is for the supply of Emgality, a 120 mg/mL injectable medication, to support military healthcare programs. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Emgality 120 mg/ml injectables. The contract has a ceiling value of $1,669.08 and runs through August 18, 2022. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,063.82, is for the delivery of Emgality 120 mg/ml Penml, a medication, on a firm fixed price basis. The contract has an ultimate completion date of June 26, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,291.13, is for the supply of the prescription medication Emgality 120 mg/ml. The contract has an ultimate completion date of April 21, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Emgality 120 mg/ml injectable medication. The $2,563.62 contract has a completion date of March 28, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical through November 2026, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $16,612.86 and covers the supply of Emgality 120 mg/ml injectable medication. The contract has a period of performance through March 13, 2025 and is structured as a firm fixed-price delivery order. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,932.23, is for the delivery of Emgality 120 mg/ml injection medication. The contract has a firm fixed price pricing type and a completion date of April 10, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of Emgality 120 mg/ml injection. The contract has a ceiling value of $1,352.40 and is a Firm Fixed Price contract. The ultimate completion date for this delivery order is August 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,179.64 firm-fixed-price contract is for the supply of Emgality 120 mg/ml pens, a prescription medication. The contract has a period of performance through September 12, 2024. This order is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FND17
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Emgality 120 mg/ml prescription medication. The contract has a total ceiling value of $1,671.20 and is set to expire on October 8, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen, through its Corporate Office division, has been a significant supplier of pharmaceutical products and medical supplies to various federal agencies, including the military healthcare system. The company holds several large Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000, respectively, for delivering a comprehensive range of medical commodities to support government healthcare programs.

Generated 1/6/25, 12:24 PM